Similar to ARID1A, the inactivation of RNF43 in combination with KRAS activation in the pancreas of mice significantly increased the incidence of high‐grade cystic lesions and pancreatic cancer.23 This evidence concerns the gene KRAS and pancreatic neoplasm.